Quarterly Brief (October - December 2023): A Current Expert Analysis on Important HIV Clinical Decisions
Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.
This educational Quarterly Brief, covering HIV data from October through December of 2023, will discuss the most clinically relevant information on HIV Prevention, ART Studies, and Comorbidities.
Faculty:Paul Sax, MD and Graeme Moyle, MD, PhD
Accreditation Type:AMA, ABS, ANCC and ACPE
Launch Date:January 22, 2024
Release Date:January 22, 2024
Expiration Date: December 31, 2024
Estimated Time to Complete Activity:0.50 hours